Austin, TX, United States of America

Haiying Chen

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The University of Texas System. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haiying Chen. Retrieved from https://idiyas.com/inventor/haiying-chen-01rfqzky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Haiying Chen in the Field of Medical Research

Introduction

Haiying Chen is a prominent inventor based in Austin, TX (US). She has made significant contributions to the field of medical research, particularly in the development of therapeutic agents. Her work focuses on the modulation of specific biological pathways that are crucial for addressing various human diseases.

Latest Patents

Haiying Chen holds a patent for "Inhibitors of bromodomain-containing protein 4 (BRD4)." This patent describes small molecule selective inhibitors of the BRD4 bromodomain. The compounds outlined in her patent can modulate the bronchiolar NFkB-BRD4 axis, which plays a vital role in the acute neutrophilic response to viral molecular patterns. These compounds have the potential to be developed as preventive and therapeutic agents for various human diseases and conditions. She has 1 patent to her name.

Career Highlights

Haiying Chen is affiliated with the University of Texas System, where she continues her research and innovation. Her work has garnered attention for its potential impact on medical treatments and understanding disease mechanisms.

Collaborations

Some of her notable coworkers include Jia Zhou and Allan R Brasier, who contribute to her research endeavors and collaborative projects.

Conclusion

Haiying Chen's innovative work in developing BRD4 inhibitors showcases her commitment to advancing medical research. Her contributions have the potential to lead to significant breakthroughs in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…